Martin Wilson, General Counsel of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), filed a Form 4 on November 9, 2026, disclosing the sale of 53,389 shares of common stock on November 5, 2026, to cover tax withholding obligations related to vesting restricted stock units.

Key Highlights

  • Reporting person: Martin Wilson, serving as General Counsel of Rocket Pharmaceuticals, Inc.
  • Transaction date: November 5, 2026, with 53,389 shares of common stock disposed of (transaction code S).
  • Sale price: $2.394 per share, according to the filing.
  • Purpose of sale: The filing states shares were sold "in order to pay tax withholding obligations in connection with the vesting of RSUs."
  • Remaining holdings: 545,100 shares beneficially owned directly following the reported transaction, including RSUs that convert to common stock on a one-for-one basis.

Wilson's RSU-Related Share Sale at Rocket Pharmaceuticals

According to the Form 4 filing, Martin Wilson, General Counsel at Rocket Pharmaceuticals, Inc., disposed of 53,389 shares of the company's common stock on November 5, 2026, at a price of $2.394 per share. The filing identifies the transaction code as "S," indicating a sale, and specifies the shares were disposed of directly by the reporting person.

The filing includes an explanatory footnote stating that the shares were sold specifically to satisfy tax withholding obligations arising from the vesting of restricted stock units. A separate footnote discloses that Wilson's total holdings include RSUs that convert to common stock on a one-for-one basis. Following the reported transaction, the filing reports Wilson's direct beneficial ownership at 545,100 shares.

No derivative securities transactions were reported in Table II of the filing. The Form 4 was filed individually by Wilson as a single reporting person, with the signature dated November 9, 2026. The issuer is identified in the filing as Rocket Pharmaceuticals, Inc., trading on NASDAQ under the symbol RCKT.

What Was Disclosed

Rocket Pharmaceuticals General Counsel Martin Wilson reported the disposal of 53,389 shares of common stock on November 5, 2026, at $2.394 per share to cover RSU-related tax withholding, leaving him with 545,100 shares directly held.